

15 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Vida Longevity Fund | May 2010 | Indefinite | $2.1B | 4,919 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
15 partners are named across this firm’s filings, 15 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| David Roberts | Active | None listed | 14 | 4 |
| Michael Gordon | Selective | None listed | 20 | 3 |
| Adam Schwartz | Slowing | Data & analytics, Developer tools & infrastructure, Sales & marketing tech | 4 | 1 |
| Dan Young | Slowing | Climate & energy, Cybersecurity, Enterprise software | 3 | 1 |
| Thomas Fuller | Slowing | Biotech & pharma, Climate & energy, Digital health | 5 | 1 |
| Arthur Peponis | Quiet | None listed | 0 | 0 |
| Blair Wallace | Quiet | None listed | 0 | 0 |
| Forest Wolfe | Quiet | None listed | 0 | 0 |
| Jeff Serra | Quiet | None listed | 0 | 0 |
| Jonathan Lieberman | Quiet | Enterprise software | 3 | 0 |
| Joseph Wekselblatt | Quiet | None listed | 0 | 0 |
| Kirk Wickman | Quiet | None listed | 0 | 0 |
| Lawrence Schloss | Quiet | None listed | 0 | 0 |
| William Tice | Quiet | None listed | 0 | 0 |
| Wilson Leung | Quiet | None listed | 0 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Classified sectors of Vida Longevity’s own portfolio companies, based on 42 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Vida Longevity’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| AG Eleven Partners | 12 | Adoreal, Aionx Antimicrobial Technologies, Ask Parable, Capra Financial, CELLCONTROL, Embed.ly, Faro Energy I, Frontier Financial Group, ITOPIA, Team Car Wash Holdings, Ticket Evolution, Videolicious |
| AG Anson Holdings | 4 | Ask Parable, Embed.ly, Frontier Financial Group, Videolicious |
| FMZ Ventures | 4 | Ask Parable, Embed.ly, Frontier Financial Group, Videolicious |
| Arthur Ventures | 1 | Circadian Risk |
A shared board seat: a company where filings name a Vida Longevity partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.